Toxicology Testing provides critical information and knowledge that can be used by regulatory agencies and healthcare professionals to put policies in place and administer treatment that limit exposure to substances, reducing the likelihood of adverse drug reactions and negative health outcomes. Toxicology tests help physicians to:

  • Monitor the patient’s therapy
  • Confirm suspected toxicity
  • Identify potential hazards due to other medications and help prevent mixed drug toxicity
  • Detect if a patient lacks a proper response
  • Monitor for patient’s compliance with therapy


The Respiratory Panel is a comprehensive panel detecting viral, bacterial, and fungal pathogens causing respiratory illness by molecular technique.

  • Acute Bronchitis
  • Common Cold
  • Acute Pharyngitis
  • Acute Tonsillitis
  • Cough and Fever
  • Wheezing
  • Pneumonia
  • Viral Infection
  • Other Nasal and Sinus Diseases

Molecular UTI

Molecular UTI- With molecular testing, not only can you receive a clear picture of the type and percent of pathogens causing the infection, in many cases, you can identify antimicrobial resistance. With the power of molecular testing, you can select the optimal medication therapy for your patient, improve treatment outcomes and reduce healthcare spend.

Urinary tract infections (UTIs) account for millions of physician office visits and hundreds of thousands of hospitalizations per year. Minor UTIs can often resolve on their own, but many UTIs can present issues when left untreated, resulting in further complications and even death.

With the evolution of multi-medication resistant organisms, clinical diagnosis of UTIs has become more complex. Up to one-third of UTIs show resistance to antibiotics. As such, the development of advanced diagnostics is critical for accurate identification of the pathogens causing the infection in your patients.
Time is of the essence because an improper diagnosis or ineffective treatment plan for a UTI could cause:

  • Ongoing discomfort
  • Chronic infections
  • Permanent kidney damage
  • Urethral narrowing in men
  • Life-threatening sepsis

Cancer Genomics

CGX is designed to provide physicians with clinically relevant information based on the genomic profile of each individual patient. Our test analyzes mutations in a patient’s DNA known to be associated with an increased risk of hereditary cancer


PGX testing can improve outcomes for patients, reduce cost for insurance companies and enhance the overall quality of care delivered by the physician. A PGX test can reduce the number of failed drug treatments, adverse drug reactions, the number of medications a patient takes before finding the right one and provide a more accurate assessment of a patient.

Patients who can benefit from PGX testing include those:

  • taking multiple medications
  • on complex drug treatment plans
  • with current prescriptions that are not working
  • and with previous adverse drug reactions (ADRs) to medications